ACAT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.325220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.531200E-01
Normal-vs-Stage2
3.923600E-02
Normal-vs-Stage3
1.320810E-01
Normal-vs-Stage4
7.124000E-02
Stage1-vs-Stage2
6.542100E-02
Stage1-vs-Stage3
2.555200E-01
Stage1-vs-Stage4
2.120400E-01
Stage2-vs-Stage3
6.201000E-01
Stage2-vs-Stage4
5.866000E-01
Stage3-vs-Stage4
9.752400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.414780E-01
Normal-vs-AfricanAmerican
9.120600E-01
Normal-vs-Asian
1.115580E-02
Caucasian-vs-AfricanAmerican
6.526000E-02
Caucasian-vs-Asian
6.927500E-02
AfricanAmerican-vs-Asian
8.817000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.869900E-02
Normal-vs-Female
2.705800E-01
Male-vs-Female
3.981600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.661200E-01
Normal-vs-Age(41-60Yrs)
2.147800E-01
Normal-vs-Age(61-80Yrs)
1.201650E-01
Normal-vs-Age(81-100Yrs)
3.400000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.296200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.356200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.466800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.884200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.229200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.958100E-02
Normal-vs-Daily Drinker
1.972160E-02
Normal-vs-Weekly Drinker
1.363050E-01
Normal-vs-Occasional Drinker
4.916400E-01
Normal-vs-Social Drinker
3.328400E-01
Non Drinker-vs-Daily Drinker
4.330200E-01
Non Drinker-vs-Weekly Drinker
6.874400E-01
Non Drinker-vs-Occasional Drinker
5.739600E-01
Non Drinker-vs-Social Drinker
4.799000E-01
Daily Drinker-vs-Weekly Drinker
3.457200E-01
Daily Drinker-vs-Occasional Drinker
3.658600E-01
Daily Drinker-vs-Social Drinker
2.604200E-01
Weekly Drinker-vs-Occasional Drinker
7.622000E-01
Weekly Drinker-vs-Social Drinker
7.225200E-01
Occasional Drinker-vs-Social Drinker
9.955400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.608600E-01
Normal-vs-Grade 2
6.250200E-01
Normal-vs-Grade 3
6.218000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.879700E-02
Grade 1-vs-Grade 3
3.997900E-02
Grade 1-vs-Grade 4
7.608600E-01
Grade 2-vs-Grade 3
9.337200E-01
Grade 2-vs-Grade 4
6.250200E-01
Grade 3-vs-Grade 4
6.218000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.138420E-01
Normal-vs-NonDiabetic
1.447200E-01
Diabetic-vs-NonDiabetic
9.509400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.351630E-02
Normal-vs-NoPancreatitis
1.737620E-01
Pancreatitis-vs-NoPancreatitis
9.784200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.188000E-01
Normal-vs-N1
4.539700E-02
N0-vs-N1
3.135000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.861000E-03
Normal-vs-TP53-NonMutant
4.380000E-01
TP53-Mutant-vs-TP53-NonMutant
1.98334999998995E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
